Posts tagged Clinical Development
BenevolentAI acquires advanced Cambridge research facility to accelerate its AI-enabled drug development

BenevolentAI acquires clinical development research facility in Cambridge to drive AI drug discovery. Acquisition creates first AI company capable of covering entire drug development process from drug discovery to clinical development.

Read More
BenevolentAI hires Head of GSK Discovery Performance Unit as VP Drug discovery

Ian Churcher joins BenevolentAI as its new VP of Drug Discovery & Preclinical Development He joins BenevolentAI from GSK where he headed a Discovery Performance Unit focussed on progressing new approaches to drug discovery including pioneering development of Protein Degradation technology.

Read More